Hubbry Logo
Imperial Chemical IndustriesImperial Chemical IndustriesMain
Open search
Imperial Chemical Industries
Community hub
Imperial Chemical Industries
logo
7 pages, 0 posts
0 subscribers
Be the first to start a discussion here.
Be the first to start a discussion here.
Imperial Chemical Industries
Imperial Chemical Industries
Imperial Chemical Industries
View on Wikipedia
from Wikipedia

Imperial Chemical Industries (ICI) was a British chemical company. It was, for much of its history, the largest manufacturer in Britain.[1] Its headquarters were at Millbank in London. ICI was listed on the London Stock Exchange and was a constituent of the FT 30 and later the FTSE 100 indices.

Key Information

ICI was formed in 1926 as a result of the merger of four of Britain's leading chemical companies. From the onset, it was involved in the production of various chemicals, explosives, fertilisers, insecticides, dyestuffs, non-ferrous metals, and paints; the firm soon became involved in plastics and a variety of speciality products, including food ingredients, polymers, electronic materials, fragrances and flavourings. During the Second World War, ICI's subsidiary ICI Nobel produced munitions for Britain's war effort; the wider company was also involved with Britain's nuclear weapons programme codenamed Tube Alloys. Throughout the 1940s and 1950s, ICI greatly expanded its activities in the pharmaceutic sector; cumulating in the formation of a dedicated subsidiary, ICI Pharmaceuticals, in 1957.

During 1960, ICI's first outsider to serve as chairman, Paul Chambers, was appointed. Chambers reorganised the company, but fell out of favour following an unsuccessful takeover bid of rival firm Courtaulds. Between 1968 and 1971, Peter Allen was chairman of ICI, during which time Viyella was purchased, the subsidiary Cleveland Potash Ltd was created, and profits dipped. Major moves in the 1970s included the acquisition of the American competitor Atlas Chemical Industries Inc. and the divestment of Imperial Metal Industries. By the late 1980s, ICI which had continued to acquire entities such as the Beatrice Chemical Division and Glidden Coatings & Resins, increasing competition and rising internal complexity were driving ICI towards major restructuring plans, including a demerger.[2]

Considerable changes at ICI came about during the 1990s, particularly in the aftermath of an unsuccessful acquisition attempt in 1991 by Hanson of the firm in what would have been the biggest takeover in British history. That same year, ICI sold its agricultural and merchandising operations of BritAg and Scottish Agricultural Industries to Norsk Hydro; it sold its nylon business to DuPont one year later. In 1993, the firm also de-merged its pharmaceutical bio-science businesses as Zeneca. During 1997, ICI's Australian subsidiary, ICI Australia, was sold in exchange for £1 billion. During 2008, ICI was acquired by AkzoNobel for £8 billion;[3] shortly thereafter, portions of ICI were sold off to Henkel while its remaining operations were integrated within AkzoNobel's existing organisation.[4]

History

[edit]

Development of the business (1926–1944)

[edit]
1930s volumes of ICI magazine

The company was founded in December 1926 from the merger of four companies: Brunner Mond, Nobel Explosives, the United Alkali Company, and British Dyestuffs Corporation.[5] ICI established its head office at Millbank in London in 1928.[5] Competing with DuPont and IG Farben, the new company produced chemicals, explosives, fertilisers, insecticides, dyestuffs, non-ferrous metals, and paints.[5] In its first year, turnover was £27 million.[5]

During the 1920s and 1930s, the company played a key role in the development of new chemical products, including the dyestuff phthalocyanine (1929), the acrylic plastic Perspex (1932),[5] Dulux paints (1932, co-developed with DuPont),[5] polyethylene (1937),[5] and polyethylene terephthalate fibre known as Terylene (1941).[5] In 1940, ICI started British Nylon Spinners as a joint venture with Courtaulds.[6][7]

ICI also owned the Sunbeam motorcycle business, which had come with Nobel Industries, and continued to build motorcycles until 1937.[8]

During the Second World War, ICI was a major participant in Britain's war economy; its subsidiary ICI Nobel was involved in the production of munitions.[9][10] The company was involved with the United Kingdom's nuclear weapons programme codenamed Tube Alloys.[11][12]

Postwar innovation (1945–1990)

[edit]
Map showing Imperial Chemical Industries sales regions, offices and factories in the United Kingdom in May 1955

In the 1940s and 1950s, the company established its pharmaceutical business and developed a number of key products, including Paludrine (1940s, an anti-malarial drug),[5] halothane (1951, an inhalational anaesthetic agent), propofol (1977, an intravenous anaesthetic agent),[13] Inderal (1965, a beta-blocker),[5] tamoxifen (1978, a frequently used drug for breast cancer),[14] and PEEK (1979, a high performance thermoplastic).[5]

During the 1950s, ICI developed a material as Crimplene, a thick polyester yarn that was used to make a fabric of the same name.[15] The resulting cloth is heavy and wrinkle-resistant, and retains its shape well. The California-based fashion designer Edith Flagg was the first to import this fabric from Britain to the United States.[16]

During 1960, Paul Chambers became the first chairman appointed from outside the company.[17] Chambers employed the consultancy firm McKinsey to help with reorganising the company.[17] Export sales doubled during his eight-year tenure export, however, Chambers' reputation was severely damaged by a failed takeover bid for Courtaulds in 1961–1962.[17][18]

On 1 August 1962, ICI's operations in Burma were nationalised following a military coup in the country.[19]

In 1964, ICI acquired British Nylon Spinners (BNS), the company it had jointly set up in 1940 with Courtaulds. ICI surrendered its 37.5 per cent holding in Courtaulds and paid Courtaulds £2 million a year for five years, "to take account of the future development expenditure of Courtaulds in the nylon field." In return, Courtaulds transferred to ICI their 50 per cent holding in BNS.[20]

Early pesticide development under ICI Plant Protection Division, with its plant at Yalding, Kent, research station at Jealott's Hill and HQ at Fernhurst Research Station included paraquat (1962, a herbicide),[5] the insecticides pirimiphos-methyl in 1967 and pirimicarb in 1970, brodifacoum (a rodenticide) was developed in 1974; in the late 1970s, ICI was involved in the early development of synthetic pyrethroid insecticides such as lambda-cyhalothrin.[21]

Peter Allen was appointed chairman between 1968 and 1971.[22] He presided over the purchase of Viyella.[22] Profits shrank under his tenure.[22] During his tenure, ICI created the wholly owned subsidiary Cleveland Potash Ltd, for the construction of Boulby Mine in Redcar and Cleveland, North Yorkshire. The first shaft was dug in 1968, with full production from 1976. ICI jointly owned the mine with Anglo American, and then with De Beers, before complete ownership was transferred to Israel Chemicals Ltd in 2002.[23]

ICI sponsored Williams Racing from 1983 to 1990.

Between 1971 and 1975, Jack Callard held the position of chairman at the firm.[24] Amid Callard's tenure, company profits almost doubled between 1972 and 1974 while ICI became Britain's largest exporter.[24] In 1971, the company acquired Atlas Chemical Industries Inc., a major American competitor.[5][25] In 1977, Imperial Metal Industries was divested as an independent quoted company.[26][27]

Between 1982 and 1987, the company was headed by the charismatic John Harvey-Jones.[28] In 1985, ICI acquired the Beatrice Chemical Division; during the following year, it also bought Glidden Coatings & Resins, a leading paints business.[29][30]

Reorganisation of the business (1991–2007)

[edit]

By the early 1990s, plans were carried out to demerge the company, as a result of increasing competition and internal complexity that caused heavy retrenchment and slowing innovation.[2] In 1991, ICI sold the agricultural and merchandising operations of BritAg and Scottish Agricultural Industries to Norsk Hydro.[31] It also divested its soda ash products arm to Brunner Mond, ending an association with the trade that had existed since the company's inception, one that had been inherited from the original Brunner, Mond & Co. Ltd.[32]

During mid 1991, ICI was subject to an attempted acquisition Hanson; by this point, ICI was commonly being viewed by investors as having been in decline and thus its valuation was depressed, making it more vulnerable to such takeover attempt.[33][34] Hanson had acquired a 2.8 per cent stake in the company as part of its hostile takeover attempt, which ICI's management team chose to oppose.[35][36] The envisioned acquisition became hotly contested and controversial, partially as it would have been the biggest takeover in British history at that point.[37] In October 1991, Hanson opted to not proceed with the deal.[33][2]

In 1992, the company sold its nylon business to DuPont.[38][39] During 1993, the company de-merged its pharmaceutical bio-science businesses: pharmaceuticals, agrochemicals, specialities, seeds and biological products were all transferred into a new and independent company called Zeneca.[2] Zeneca subsequently merged with Astra AB to form AstraZeneca.[40]

In 1994, Charles Miller Smith was appointed CEO of ICI, one of the few times that an external figure had been appointed to lead the firm, Miller-Smith having previously been a director at Unilever. Shortly afterwards, the company acquired a number of former Unilever businesses in an attempt to move away from its historical reliance on commodity chemicals. During 1995, ICI acquired the American paint companies Devoe Paints,[41] Fuller-O'Brien Paints[42] and Grow Group.[43] In 1997, ICI acquired National Starch & Chemical, Quest International, Unichema, and Crosfield, the speciality chemicals businesses of Unilever in exchange for $8 billion.[44][45] This step was part of a strategy to move away from cyclical bulk chemicals and to progress up the value chain to become a higher growth, higher margin business.[5] Later that same year, it went on to buy Rutz & Huber, a Swiss paints business.[46]

Having taken on some £4 billion of debt to finance these acquisitions, the company was soon compelled to sell off its commodity chemicals businesses:

Having sold much of its historically profitable commodities businesses, and many of the new speciality businesses which it had failed to integrate, the company consisted mainly of the Dulux paints business, which found itself the subject of a takeover by AkzoNobel in 2007.[58]

Takeover by AkzoNobel

[edit]
A former ICI plant in Huddersfield, West Yorkshire, now owned by Syngenta.

In June 2007, the Dutch firm AkzoNobel (owner of Crown Berger paints) bid £7.2 billion (€10.66 billion or $14.5 billion) for ICI. An area of concern about a potential deal was ICI's British pension fund, which had a deficit of almost £700 million and future liabilities of more than £9 billion at the time.[59] Regulatory issues in the UK and other markets where Dulux and Crown Paints brands each have significant market share were also a cause for concern for the boards of ICI and AkzoNobel. In the UK, any combined operation without divestments would have seen AkzoNobel have a 54 per cent market share in the paint market.[60] The initial bid was rejected by the ICI board and the majority of shareholders.[61] However, a subsequent bid for £8 billion (€11.82 billion) was accepted by ICI in August 2007, pending approval by regulators.[62]

On 2 January 2008, completion of the takeover of ICI plc by AkzoNobel was announced.[3] Shareholders of ICI received either £6.70 in cash or AkzoNobel loan notes to the value of £6.70 per one nominal ICI share. The adhesives business of ICI was transferred to Henkel as a result of the deal,[63] while AkzoNobel agreed to sell its Crown Paints subsidiary to satisfy the concerns of the European Commissioner for Competition.[64] The areas of concern regarding ICI's British pension scheme were addressed by ICI and AkzoNobel.[65]

Operations

[edit]

ICI operated a number of chemical sites around the world. In the UK, the main plants were as follows:

  • Billingham Manufacturing Plant (in Stockton-on-Tees) and Wilton (in present-day Redcar and Cleveland): ICI used the Billingham site to manufacture fertilisers in the 1920s and went on to produce plastics at Billingham in 1934. During World War II it manufactured Synthonia, a synthetic ammonia for explosives.[66] The Wilton R&D site was built to support the plastics division with R&D and chemical engineering facilities. The ICI Billingham Division was split into the ICI Heavy Organic Chemicals Division and ICI Agricultural Division in the 1960s. From 1971 to 1988 ICI Physics and Radioisotopes Section (later known as Tracerco) operated a small General Atomics TRIGA Mark I nuclear reactor at its Billingham factory for the production of radioisotopes used in the manufacture of flow and level instruments, among other products.[67] The Agricultural Division was noted for the development of the world's largest bioreactor at the time – the 1.5 million litre Pruteen Reactor, used for the cultivation of animal feed. Engineering models of components and the builder's model of the complete plant are now in the collection of the Science Museum London Archived 19 November 2021 at the Wayback Machine. Pruteen had limited economic success but was followed by the much more successful development of Quorn.
  • Blackley (in Manchester) and Huddersfield: ICI used the sites to manufacture dyestuffs. The dye business, known as the ICI Dyestuffs Division in the 1960s, went through several reorganisations. Huddersfield was tied in with Wilton with the production of nitrobenzene and nitrotoluene. Huddersfield also produced insecticides. (Syngenta still manufacture insecticides at Huddersfield). Proxel Biocide was made at Huddersfield from the 80s onwards. Additives also made at Huddersield. Huddersfield became Zeneca then AstraZeneca, in 2004 Huddersfield was Syngenta, Avecia, Arch and Lubrizol running what were all ICI plants at one time. Through the years it was combined with other speciality chemicals businesses and became Organics Division. Then became ICI Colours and Fine Chemicals and then ICI Specialties.[68]
  • Buxton (in Derbyshire): ICI Lime Division was formed in 1927 with the acquisition of Buxton Lime Firms. Quarrying started at Tunstead in 1929 and it became the largest limestone quarry in the UK. In 1992 ICI sold its Lime Division to Anglo American as part of its UK Tarmac operation.[69][70]
  • Runcorn (in Cheshire): ICI operated a number of separate sites within the Runcorn area, including the Castner-Kellner site, where ICI manufactured chlorine and sodium hydroxide (caustic soda).[71] Adjacent to the Castner-Kellner site was Rocksavage works, where a variety of chemicals based on chlorine products were manufactured, including Chloromethanes, Arklone dry-cleaning fluid (Trichlorotrifluoroethane), Trichloroethylene degreasing fluid and the Arcton range of CFCs. Also on that site were PVC manufacture and HF (Hydrogen fluoride) manufacture. At Runcorn Heath Research Laboratories, technical support, research and development for Mond Division products was carried out, and the support sections included chemical plan design and engineering sections. Just to the north of Runcorn, on an island between the Manchester Ship Canal and the River Mersey could be found the Wigg Works, which had been erected originally for producing poison gas in wartime. In Widnes could also be found several factories producing weedkillers and other products. For many years it was known as ICI Mond Division but later became part of the ICI Chemicals and Polymers Division. The Runcorn site was also responsible for the development of the HiGEE and Spinning Disc Reactor concepts. These were originated by Professor Colin Ramshaw and led to the concept of Process Intensification; research into these novel technologies is now being pursued by the Process Intensification Group at Newcastle University.[72]
  • Winnington and Wallerscote (in Northwich, Cheshire): It was here that ICI manufactured sodium carbonate (soda ash) and its various by-products such as sodium bicarbonate (bicarbonate of soda), and sodium sesquicarbonate. The Winnington site, built in 1873 by the entrepreneurs John Tomlinson Brunner and Ludwig Mond, was also the base for the former company Brunner, Mond & Co. Ltd. and, after the merger which created ICI, the powerful and influential Alkali Division. It was at the laboratories on this site that polythene was discovered by accident in 1933 during experiments into high pressure reactions.[73] Wallerscote was built in 1926, its construction delayed by the First World War, and became one of the largest factories devoted to a single product (soda ash) in the world.[74] However, the decreasing importance of the soda ash trade to ICI in favour of newer products such as paints and plastics, meant that in 1984 the Wallerscote site was closed, and thereafter mostly demolished. The laboratory where polythene was discovered was sold off and the building became home to a variety of businesses including a go-kart track and paintballing, and the Winnington Works were divested to the newly formed company, Brunner Mond, during 1991. It was again sold in 2006, to Tata (an Indian-based company) and in 2011 was rebranded as Tata Chemicals Europe. The Winnington plant closed in February 2014, with the last shift on 2 February bringing to a close 140 years of soda ash production in this Northwich site.[citation needed]
  • Ardeer (in Stevenston, Ayrshire): ICI Nobel used the site to manufacture dynamite and other explosives and nitrocellulose-based products. For a time, the site also produced nylon and nitric acid. Nobel Enterprises was sold in 2002 to Inabata.[75]
  • Penrhyndeudraeth (Gwynedd, North Wales): Cooke's Works, part of ICI's Nobel's Explosives Company division produced nitroglycerine-based explosives up until the site's closure in 1995.
  • Slough (in Berkshire): Headquarters of ICI Paints Division.[76]
  • Stowmarket : Plant Manufacturing White, and off white Paints
  • Prudhoe - Plant Manufacturing Hammerite Paints
  • Birmingham: Plant Manufacturing Packaging Coatings for food and beverage cans
  • Welwyn Garden City (in Hertfordshire): Headquarters of ICI Plastics Division until the early 1990s.[77]

Argentina

[edit]

An ICI subsidiary called Duperial operated in Argentine from 1928 to 1995, when it was renamed ICI.

Established in the city of San Lorenzo, Santa Fe, it operates an integrated production site with commercial offices in Buenos Aires. Since 2009 it has made sulphuric acid with ISO certification under the company name Akzo Nobel Functional Chemicals S.A.[citation needed]

It also had an operation at Palmira, Mendoza, for its Wine Chemicals Division, that manufactured tartaric acid, wine alcohol and grapeseed oil from natural raw material coming from the wine industry in the provinces of Mendoza and San Juan. This operation held 10% world market share for tartaric acid. It was sold in 2008 and currently operates as Derivados Vínicos S.A. (DERVINSA).[78]

Australia

[edit]

The subsidiary ICI Australia Ltd established the Dry Creek Saltfields at Dry Creek north of Adelaide, South Australia, in 1940, with an associated soda ash plant at nearby Osborne. In 1989, these operations were sold to Penrice Soda Products.[79]

An ICI plant was built at Botany Bay in New South Wales in the 1940s and was part of the Orica demerger in 1997.[80] This plant once manufactured paints, plastics and industrial chemicals such as solvents. It had been detirmined to be the source of the Botany Bay Groundwater Plume contamination of a local aquifer.[80][81]

Bangladesh

[edit]

In 1968 a subsidiary of Imperial Chemical Industries (ICI) was established in then-East Pakistan. After Bangladesh gained independence in 1971, the company was incorporated on 24 January 1973[82] as ICI Bangladesh Manufacturers Limited and also as Public Limited Company. The company divested its investment in Bangladesh and was renamed as Advanced Chemical Industries Limited (ACI Limited) on 5 May 1992. The company sold its insect control, air care and toilet care brands to SC Johnson & Son in 2015.[83] Currently Advanced Chemical Industries (ACI) Limited is one of the largest conglomerates in Bangladesh with a multinational heritage operating across the country.[84] The company operates through three reporting divisions: Pharmaceuticals, Consumer Brands and Agribusiness.[85]

Sri Lanka

[edit]

ICI maintained offices in Colombo importing and supplying chemicals for manufacturers in Ceylon. In 1964, following import restrictions that allowed only locally owned subsidiaries of multinational companies to gain import licenses, Chemical Industries (Colombo) Limited was formed as an ICI subsidiary with 49% ICI ownership and remaining held public.[86]

New Zealand

[edit]

The subsidiary ICI New Zealand provided substantial quantities of chemical products – including swimming pool chemicals, commercial healthcare products, herbicides and pesticides for use within New Zealand and the neighbouring Pacific Islands.

A fire at the ICI New Zealand store in Mount Wellington, Auckland, on 21 December 1984, killed an ICI employee and caused major health concerns. Over 200 firefighters were exposed to toxic smoke and effluents during the firefighting efforts. Six firefighters retired for medical reasons as a result of the fire. This incident was a major event in the history of the New Zealand Fire Service and subject to a formal investigation, led by future Chief Justice Sian Elias. The fire was a trigger for major reforms of the service; direct consequences included improved protective clothing for firefighters, a standard safety protocol for major incidents, the introduction of dedicated fireground safety officers, and changes to occupational health regulations.[87][88]

See also

[edit]

References

[edit]

Further reading

[edit]
Revisions and contributorsEdit on WikipediaRead on Wikipedia

Imperial Chemical Industries

View on Grokipedia
from Grokipedia

Imperial Chemical Industries plc (ICI) was a British multinational manufacturing company specializing in chemicals, formed on 7 1926 through the merger of four leading domestic firms: Brunner Mond & Co., Nobel Industries Ltd., the United Alkali Company Ltd., and the British Dyestuffs Corporation Ltd. Headquartered in , ICI rapidly expanded to dominate the British chemical sector and achieve global prominence, producing a wide array of products including alkalis, explosives, fertilizers, dyestuffs, paints, and general chemicals. At its peak, the company employed tens of thousands and maintained extensive operations worldwide, contributing significantly to industrial advancements in materials and processes. However, ICI faced antitrust scrutiny, notably in U.S. courts for agreements with firms like that divided international markets for explosives and chemicals, leading to decrees prohibiting such territorial allocations. By the 1990s, amid competitive pressures and strategic shifts, ICI demerged its pharmaceuticals business into Zeneca in 1993 to focus on specialties, though the core chemicals operations struggled and were ultimately acquired by Dutch rival Akzo Nobel in 2008 for £8 billion, marking the end of ICI as an independent entity.

History

Formation and Early Expansion (1926–1939)

Imperial Chemical Industries (ICI) was established on December 7, 1926, through the merger of four leading British chemical firms: Nobel Industries Ltd., Brunner, Mond & Co. Ltd., the United Alkali Company Ltd., and the British Dyestuffs Corporation Ltd. This consolidation, the largest merger in British industrial history at the time, aimed to rationalize a fragmented sector plagued by overcapacity and inefficient competition, enabling economies of scale to rival international giants such as Germany's IG Farbenindustrie and the United States' DuPont. Sir Harry McGowan, formerly of Nobel Industries, became the first chairman, while Sir Alfred Mond of Brunner Mond served as a key architect and initial managing director, steering the new entity toward centralized control and vertical integration across chemicals, explosives, and dyestuffs. Upon commencing operations in 1927, ICI employed approximately 33,000 workers and organized its activities into nine divisions, encompassing alkalis, products, dyestuffs, explosives, s, general chemicals, leathercloth, lime, and metals. Headquarters were established at Millbank in by 1928, facilitating coordinated management. The company prioritized production as a core growth area, allocating 10% of its capital—equivalent to £20 million—to construct a massive synthetic plant at , , which became operational in the late 1920s to capitalize on technologies inherited from Brunner Mond. However, global agricultural depression in the early 1930s led to surplus supply, prompting temporary closure of parts of the facility and a strategic pivot toward dyestuffs and emerging synthetics. Expansion efforts included international cartel arrangements to stabilize markets amid post-World War I trade disruptions. In 1929, ICI negotiated production quotas with IG Farben for nitrogen compounds, a critical fertilizer input, followed by a 1935 agreement delineating sales territories: ICI retained dominance in the United Kingdom, Spain, Portugal, and certain colonies, while IG Farben controlled much of continental Europe, Asia, and the Americas. Domestically, ICI pursued rationalization by shuttering redundant plants from predecessor firms and investing in research facilities, fostering innovations such as the 1933 accidental discovery of polyethylene by chemists Reginald Gibson and Eric Fawcett during high-pressure experiments on ethylene. Patented in 1937, this polymer was initially developed for electrical insulation, with production scaling to support British rearmament from 1936 onward, including adaptations for radar cables by 1939. By the late , ICI's early growth had solidified its position as Britain's preeminent chemical producer, with revenues bolstered by government contracts for explosives and strategic materials amid rising geopolitical tensions. The company's emphasis on applied and efficiencies—rooted in the merger's mandate for technological parity with foreign competitors—laid groundwork for wartime contributions, though overinvestment highlighted risks of misaligned market forecasts in a protectionist era.

World War II and Wartime Production (1939–1945)

With the outbreak of war on September 3, 1939, Imperial Chemical Industries (ICI) rapidly reoriented its operations to support the British war effort, leveraging its prewar expertise in explosives inherited from Nobel Industries to produce munitions at scale across multiple sites. Facilities such as Ardeer in continued and expanded production of high explosives, detonators, and propellants, drawing on established infrastructure from the First World War era. Similarly, the Powfoot site, established in 1940, manufactured , nitro-cellulose powder, and later high explosives, contributing directly to and ordnance needs. ICI's subsidiary, operating under the Nobel legacy, became a cornerstone of Britain's munitions supply, with output integrated into broader contracts for bombs, shells, and fuses. Synthetic at proved critical for fillers, as the facility shifted emphasis from fertilizers to "Synthonia"—ICI's branded synthetic ammonia—essential for and other nitrate-based munitions. The site's petrol plant was repurposed to generate aviation spirit from , supporting RAF fuel demands amid shortages from continental supply disruptions. These adaptations underscored ICI's role in securing raw chemical intermediates, with 's output enabling sustained production of TNT and other high explosives despite bombing threats and resource constraints. Wartime government oversight, including allocation of labor and materials, accelerated capacity, though exact tonnage figures remain classified or undocumented in public records. ICI also advanced defensive chemical capabilities, constructing facilities for production ahead of escalation risks; a plant at Wigg Island began operations in 1938, with output later transferred to Rhydymwyn Valley Works by 1942 for enhanced security and scale. This involved five specialized buildings, two of which actively synthesized the agent, stockpiling it as a deterrent against Axis use of chemical weapons. Beyond conventional armaments, ICI contributed to the atomic program through research on (UF6) processing and enrichment techniques, conducted covertly at sites like under wartime secrecy protocols. These efforts, while peripheral to ICI's core chemical output, aligned with broader Allied strategic priorities, though production remained experimental until integration with the . By 1945, ICI's 25 plants supplied alloys, light metals, and specialty chemicals to virtually every sector of Britain's military-industrial complex, mitigating vulnerabilities exposed by early defeats.

Postwar Growth and Diversification (1945–1970)

![ICI UK Works Map May 1955.png][float-right] Following the end of , Imperial Chemical Industries (ICI) pursued aggressive expansion amid Britain's industrial reconstruction and rising global demand for chemicals in consumer and industrial applications. The company rebuilt war-damaged facilities and invested in new capacities, particularly in , leveraging abundant and gas resources for feedstock. A pivotal development was the 1952 commissioning of the Wilton chemical complex on , which integrated heavy and became a cornerstone for ethylene-based production, enabling downstream diversification into plastics and synthetic fibers. Diversification accelerated as ICI shifted from traditional inorganic chemicals toward high-value organics and specialties. Synthetic fibers emerged as a key growth area: production commenced commercially in 1946 at , following technology licensing from DuPont, while ICI's proprietary Terylene fiber—developed prewar but scaled postwar—entered full production in the mid- at a dedicated plant near Wilton. Concurrently, the pharmaceuticals division was formalized in the early 1950s, with laboratories established at to explore therapeutic agents, marking ICI's entry into life sciences amid postwar healthcare advancements. By the 1960s, ICI's portfolio encompassed paints, explosives, agrochemicals, and emerging materials like , supported by substantial R&D expenditures that sustained . Sales volumes expanded markedly, with the company's global footprint growing through subsidiaries and joint ventures, though domestic operations remained central as depicted in contemporaneous maps of facilities. This era solidified ICI's position as a leading multinational, though it faced challenges from nationalization debates under Labour governments and intensifying international competition.

Stagnation and Internal Challenges (1970–1990)

During the 1970s, Imperial Chemical Industries encountered stagnating profitability amid global overcapacity in key sectors and macroeconomic shocks, including the and oil crises that raised feedstock costs for . Between 1970 and 1972, the company's profits declined by 13 percent, while leading U.S. chemical firms saw increases of 18 to 26 percent, highlighting ICI's eroding competitive edge in bulk chemicals, plastics, and synthetic fibers. Profits peaked at £568.6 million in 1974 before plummeting 33 percent in 1975 due to depressed demand and excess capacity in these markets. Internal inefficiencies, such as outdated production facilities and a conservative managerial approach, compounded these pressures, though reforms—shifting to weekly pay and incentive structures—yielded an 11 percent productivity gain by the early decade's end. By the late , intensified competition from low-cost producers in the , , and the further eroded margins on commodity chemicals, with ICI's reliance on unprofitable diversification into fibers and fertilizers proving unsustainable. Pretax earnings fell from $1.4 billion in 1979 to $645 million in 1980 on sales of $12.4 billion, culminating in the company's first operating losses in the final two quarters of 1980 and its inaugural annual deficit of £20 million, which necessitated a reduction. These setbacks reflected deeper internal challenges, including bureaucratic and slow adaptation to market shifts, as evidenced by persistent overcapacity in plastics and , which incurred a $121 million loss worldwide in the first half of 1982 alone. The appointment of as chairman in 1982 marked an aggressive response to these issues, with reforms emphasizing cost-cutting, plant closures, workforce reductions, and divestitures of low-margin assets like soda ash and industrial explosives to refocus on higher-value pharmaceuticals, agrochemicals, and specialty polymers. Profits doubled to $939 million by 1983 and reached £1 billion in the mid-1980s, temporarily alleviating stagnation. However, underlying vulnerabilities persisted, as a 12 percent profit decline in 1985—driven by the strong , bulk chemical weakness, and falling demand—underscored incomplete structural adjustments amid ongoing global commoditization and regional production shifts.

Demergers, Restructuring, and Decline (1991–2007)

In response to intensifying global competition and a hostile takeover bid from Hanson PLC in , ICI launched a comprehensive program that included substantial cost reductions and asset rationalization. The initiative incurred a one-off charge of £949 million in 1992 to fund severance and facility closures, targeting annual savings of £400 million by 1995 through the elimination of approximately 9,000 jobs across its operations. This restructuring peaked with the demerger of ICI's pharmaceuticals, agrochemicals, and specialty chemicals divisions into the independent Zeneca Group PLC in 1993, creating two separate entities to sharpen focus and enhance shareholder value amid conglomerate inefficiencies. Zeneca received the bulk of ICI's research capabilities, particularly in genetics and molecular biology, while ICI retained commodity chemicals, paints, explosives, and basic materials businesses. The split was structured via a dividend declaration and share issuance to ICI shareholders, with Zeneca shares allocated proportionally, though ICI's post-demerger half-year operating profits in 1993 hovered around £150 million, reflecting ongoing pressures in its core segments. Following the , ICI sought to pivot toward higher-margin specialties by acquiring Unilever's Quest, Crosfield, and Pinfa businesses in 1997 for £4.8 billion, aiming to bolster adhesives, catalysts, and personal care ingredients amid declining profitability. However, the deal saddled ICI with elevated levels, exacerbating vulnerability to price volatility and overcapacity in bulk chemicals. Pre-tax profits had already declined 36% to $1.88 billion in 1990, a trend that persisted as segments faced erosion from low-cost Asian competitors. To alleviate debt and streamline operations, ICI divested its polyurethanes, , and petrochemicals units to U.S.-based in 1999 for approximately £1.65 billion ($2.8 billion), forming joint ventures that Huntsman later fully acquired by 2001–2003 through put options and buyouts valued at around $500 million for ICI's remaining stakes. These sales left ICI increasingly concentrated on paints and coatings (e.g., brand) and salt production, but persistent global oversupply, rising energy costs, and strategic overextension failed to reverse profitability erosion. By the mid-2000s, ICI grappled with annual losses and further restructurings, culminating in pressures and positioning it for eventual foreign acquisition.

Acquisition by AkzoNobel and Dissolution (2008–Present)

In August 2007, Dutch multinational Akzo Nobel announced its agreement to acquire Imperial Chemical Industries (ICI) for approximately £8 billion (equivalent to $16.2 billion at the time), aiming to bolster its global position in decorative paints and coatings through ICI's established brands like Dulux. The deal valued ICI shares at 670 pence each, plus a special dividend of 5 pence per share for ICI shareholders upon completion. This acquisition followed ICI's prolonged decline amid competitive pressures and prior demergers, positioning Akzo Nobel to integrate ICI's assets into its operations while addressing antitrust concerns through mandated divestitures, such as selling ICI's adhesives business to Henkel. The acquisition was finalized on January 2, 2008, with Akzo Nobel securing 100% of ICI's share capital, primarily through cash payments, after regulatory approvals including from the European Commission, which required the sale of overlapping assets to maintain competition. ICI's shares were subsequently delisted from the London Stock Exchange, marking the end of its 82-year history as an independent entity. Akzo Nobel restructured its organization to incorporate ICI's operations, focusing on synergies in the decorative coatings segment, which gained a leading foothold in North America, the largest such market globally. Post-acquisition integration involved consolidating ICI's paints and specialty chemicals units into Akzo Nobel's framework, realizing cost savings through headcount reductions and operational efficiencies, particularly in . However, the deal contributed to financial strain, including a €1.2 billion impairment charge on ICI-related goodwill, resulting in Akzo Nobel reporting a €1.1 billion net loss for amid broader economic downturns. ICI's core brands, such as , were retained and globalized under Akzo Nobel, transitioning from ICI's multi-local model to a unified strategy. By 2012, Akzo Nobel divested non-core ICI legacy assets, including its 76% stake in , which produced fibers, soda ash, and paints, to streamline focus on high-margin coatings. ICI itself was effectively dissolved as a distinct corporate entity, with its operations fully absorbed or rationalized into (rebranded as in 2008), ending any separate legal or operational identity. As of 2025, decorative paints division continues to leverage ICI's historical innovations, though subsequent corporate restructurings, such as the 2018 spin-off of its chemicals business to Venator Materials, have further distanced remaining ICI elements from their origins.

Products and Technologies

Core Chemical Products

Upon its formation in 1926 through the merger of Brunner Mond, United Alkali Company, Nobel Industries, and British Dyestuffs Corporation, Imperial Chemical Industries (ICI) established core chemical products centered on alkali chemicals, general inorganic chemicals, and synthetic dyestuffs, which formed the backbone of its early operations. These products leveraged inherited technologies, such as the for alkalis and electrolytic methods for , enabling ICI to supply essential industrial feedstocks for glassmaking, soap production, textiles, and agriculture. Alkali products, primarily soda ash (sodium carbonate) and caustic soda (), were key outputs from the Brunner Mond and United Alkali divisions. Soda ash was manufactured on a large scale using the Solvay ammonia-soda process at sites like , supporting demand in detergents and . Caustic soda production, often co-generated with , utilized mercury-cell inherited from United Alkali's Castner-Kellner works, yielding high-purity sodium hydroxide for pulp and paper industries. General chemicals encompassed chlorine, acids such as hydrochloric and sulfuric, and synthetic ammonia, with the latter produced at the Billingham complex starting from pre-merger developments in 1924. Synthetic ammonia, fixed via the Haber-Bosch process, served as a precursor for nitrogen fertilizers like ammonium nitrate and sulfate, addressing agricultural needs amid post-World War I demand fluctuations; by 1929, ICI coordinated global nitrogen quotas with IG Farben to stabilize overproduction. Chlorine and acids supported downstream applications in bleaching, water purification, and metal processing. Synthetic dyestuffs, derived from coal-tar intermediates like and , originated from British Dyestuffs Corporation and were vital for textiles and wartime armaments. ICI's dyestuffs division innovated with pigments in 1929, enhancing colorfastness for industrial dyes. These core products underpinned ICI's , with annual outputs scaling to meet interwar export demands, though subject to agreements limiting overcapacity in alkalis and .

Paints, Coatings, and Materials

ICI's involvement in paints and coatings began with the formation of Nobel Chemical Finishes, a between Nobel Industries (an ICI constituent) and Du Pont, which introduced Belco enamel for automotive body finishes. That year, ICI also acquired Naylor Brothers (), integrating their operations into facilities at for production and technical services. In 1932, the company launched , a durable alkyd-based gloss co-developed with Du Pont using their formulations, marking a significant advancement in weather-resistant household coatings. By 1935, ICI had acquired Du Pont's stake in Nobel Chemical Finishes and purchased British Paint and Lacquer Co., consolidating its position in lacquers and industrial finishes. The Paints Division was formally established in 1945, focusing on decorative, industrial, and automotive coatings, with Slough serving as a key hub for development and demonstration. ICI expanded its portfolio through acquisitions, including Glidden Paint in 1986, which boosted annual paint shipments by approximately 7% from 1986 to 1988. Brands under ICI included Dulux for decorative paints, Hammerite for metal protection, Cuprinol for wood preservatives, and Valentine and Coral for regional markets. The division exhibited advanced car finishes at the 1963 British Motor Show, highlighting innovations in durable, high-gloss automotive coatings. At its peak, ICI held leading global positions in paints and coatings production, supplying markets for both consumer and industrial applications. In materials, ICI produced (TiO₂) essential for opacity and durability, starting with the 1933 formation of British Titan Products Ltd., a including ICI for pigment manufacturing. This chloride-process TiO₂ was scaled at sites like , reaching over 100,000 tonnes annual capacity by the late before divestiture. ICI's encompassed , polyurethanes, acrylics, and polymers such as —discovered accidentally in 1933 and commercialized for insulation and —and (Terylene, developed post-1941 for fibers and films). The ICI Plastics Division, formed in 1937, advanced polyethylene molding and products like Perspex acrylic sheet for optical and structural uses. These materials supported coatings applications, including resins for formulation, but ICI divested much of this portfolio in the late and early , selling polyurethanes and TiO₂ to Huntsman in 1999, acrylics to in 2001, and other businesses in 2000 to refocus on core paints.

Pharmaceuticals and Agrochemicals

ICI's entry into pharmaceuticals began with wartime production of penicillin, leveraging fermentation expertise from its alkali and dyestuffs operations, before formalizing the division as ICI Pharmaceuticals in 1957. This unit prioritized cardiovascular and therapeutics, yielding (Inderal), the inaugural beta-blocker launched in 1965 for managing , , and arrhythmias through non-selective blockade of beta-adrenergic receptors. (Nolvadex), developed as an anti- agent, received approval on November 29, 1973, for treating advanced ; its activity on estrogen receptors enabled tumor regression in hormone-responsive cases, establishing it as a standard endocrine with annual global sales exceeding $1 billion by the 1990s. Additional advances included goserelin (Zoladex), a depot formulation introduced in 1987 for prostate and palliation via hormonal suppression, and (Casodex), a non-steroidal anti-androgen approved in 1995 for advanced to inhibit androgen signaling. The portfolio, housed in ICI's Plant Protection Division from the 1940s, emphasized herbicides and pesticides to enhance crop yields amid post-war agricultural intensification. Key developments included (Gramoxone), a bipyridyl whose herbicidal efficacy was identified in 1955 and commercialized by ICI in 1961; its fast-acting of foliage, combined with rapid soil inactivation, supported no-till conservation farming by controlling weeds without tillage disruption. ICI also contributed to synthetic herbicides, with research yielding compounds like 2,4-D for selective broadleaf control in cereals, influencing global weed management practices from the mid-20th century. These products drove agrochemical revenues, though faced scrutiny for risks, prompting regulatory restrictions in various markets by the 1990s. In December 1993, ICI demerged its pharmaceuticals, agrochemicals, and bioscience specialties—accounting for approximately 40% of group turnover—into the standalone Zeneca Group PLC, valued at around £6 billion at listing, to sharpen focus amid competitive pressures in life sciences distinct from commoditized chemicals. Zeneca sustained ICI's legacy through subsequent consolidations: its pharmaceuticals merged with Sweden's on April 6, 1999, forming PLC with a of $27 billion; meanwhile, the agrochemicals unit combined with Agribusiness on November 13, 2000, creating AG for integrated crop protection solutions. This separation reflected causal pressures from divergent market dynamics, where biosciences demanded high R&D investment yielding patent-protected margins, unlike cyclical bulk chemicals.

Explosives and Specialty Chemicals

ICI's explosives operations traced their roots to Nobel Industries Limited, established through the British Dynamite Company founded in 1867 by for production, with manufacturing commencing at the Ardeer site near , , in 1873. By 1926, Nobel Industries, encompassing subsidiaries like Nobel's Explosives Co Ltd with £240,000 capital from reorganizations dating to 1877, merged into the newly formed ICI, forming the Nobel Division responsible for explosives, propellants, and related nitrocellulose-based products such as varnishes and inks. This division specialized in high explosives like and blasting gelatin, alongside ammonium nitrate-based formulations, supporting , quarrying, and military applications. During World War II, ICI's Nobel Division significantly expanded production to meet Allied demands, manufacturing munitions, nitrogen-based propellants, and synthetic derivatives essential for fillers at facilities including and Ardeer. The Ardeer site, operational since the 1870s, became a key hub for shell fillings and warheads, employing thousands and contributing to Britain's wartime output amid heightened security measures following earlier incidents like the 1924 OPP () explosion that killed over 100 workers. , the division adapted to civilian uses, producing commercial s for and while innovating safer emulsion-based formulations. In parallel, ICI developed broader specialty chemicals, leveraging explosives expertise in fine chemicals, catalysts, and performance materials. The division produced industrial adhesives, specialty starches for paper and textiles, fragrances, flavors, and ingredients, alongside process intermediates for pharmaceuticals and polymers. By the , as ICI reoriented toward high-value specialties, the explosives business was reclassified under ICI Specialties, emphasizing and for inks and coatings, though it faced divestitures; the Nobel explosives operations were ultimately spun off as in the early 2000s before acquisition by . This shift reflected ICI's strategic pivot from bulk commodities to niche, high-margin products, with annual sales from specialties exceeding traditional lines by the late .

Innovations and Achievements

Major Scientific Breakthroughs

Imperial Chemical Industries (ICI) achieved several pivotal advancements in during the early , most notably the accidental discovery of in 1933. Researchers Reginald Gibson and Eric Fawcett, working at ICI's laboratories in Winnington, , observed the formation of a waxy solid during high-pressure experiments involving gas and , intended to explore reaction mechanisms under extreme conditions of up to 1,800 atmospheres. This unintended polymerization yielded (LDPE), which ICI patented in 1936 after scaling up production challenges, initially applying it as an electrical insulator for cables during before broader commercialization as a versatile . The material's properties—lightweight, chemically resistant, and moldable—revolutionized , , and consumer goods, with global production exceeding 100 million tons annually by the . In parallel, ICI pioneered transparent acrylic materials, developing Perspex (polymethyl methacrylate, or PMMA) as a shatter-resistant alternative to . Originating from in at ICI's site, the polymer was trademarked in 1934 and entered commercial production by 1936, leveraging techniques to produce clear sheets with optical clarity rivaling but weighing half as much. Initially targeted for canopies and vehicle windscreens due to its impact resistance—surviving bullets without shattering—Perspex found postwar applications in , , and medical devices, such as intraocular lenses. This innovation stemmed from systematic monomer synthesis, including , addressing limitations of earlier materials that degraded under UV exposure. ICI's contributions extended to synthetic fibers with Terylene, the company's branded (PET) , first produced commercially in 1951 at its Preston facility. Building on interwar research into polyesterification of and , ICI overcame polymerization hurdles to create strong, crease-resistant fibers suitable for textiles. Terylene's durability and washability transformed apparel and markets, with initial output reaching 11 million pounds annually by the mid-1950s, later licensed internationally and influencing DuPont's Dacron variant. This development marked a shift from natural to fully synthetic fabrics, enabling scalable production via melt-spinning processes. In pharmaceuticals, ICI's Alderley Park division under James Black synthesized in 1962, the inaugural beta-adrenergic blocker for cardiovascular therapy. Targeting and by competitively inhibiting adrenaline at beta receptors—without the partial agonist effects of predecessors like pronethalol— (marketed as Inderal from 1965) reduced heart workload and arrhythmias. Clinical trials confirmed its efficacy in lowering mortality from heart conditions, earning Black a share of the 1988 in Physiology or Medicine. This receptor-based approach influenced subsequent , spawning a class treating over 30 million patients annually worldwide.

Research and Development Infrastructure

Imperial Chemical Industries (ICI) implemented a decentralized (R&D) infrastructure upon its formation in , assigning dedicated laboratories to each division to support specialized chemical and technological advancements. This model emphasized divisional autonomy, enabling focused innovation in areas such as inorganic chemicals, polymers, agrochemicals, and pharmaceuticals, with R&D gaining prominence from the mid-1930s onward. Post-World War II, ICI allocated an average of 2-2.5% of sales to R&D, expanding personnel through drives. In northwest , the Division maintained the Winnington Laboratory near , , as its research headquarters, where was accidentally discovered in 1933 by chemists Reginald Gibson and Eric Fawcett during experiments on reactions under high pressure. The General Chemicals Division operated facilities at for inorganic and process research. The Dyestuffs Division, centered at near , conducted work on synthetic dyes, pharmaceuticals, and herbicides like . Fertilizer and polymer research occurred at in northeast , contributing to developments such as the single-cell protein () process and urea-formaldehyde resins. Explosives research, including nitrocellulose applications, was based at Ardeer in . For crop protection, ICI established Jealott's Hill Research Station near , , in 1928 as an experimental farm and unit aimed at long-term agricultural prosperity through chemical innovations, yielding products like the insecticide in the 1930s and the hormone weedkiller in the 1940s. Pharmaceutical R&D was headquartered at Alderley Park in from the , where ICI developed beta-blockers such as and initiated cancer research programs, including early work on . Additional included the Wilton site in northeast , opened in 1952, which integrated R&D for plastics, production, and organic chemicals alongside capabilities. This network of facilities underpinned ICI's portfolio, exceeding 33,000 inventions by the late .

Economic and Industrial Contributions

Imperial Chemical Industries (ICI), formed in 1926 through the merger of four leading British firms—Brunner, Mond & Co., Nobel Industries, United Company, and British Dyestuffs Corporation—rapidly established itself as the dominant force in the UK's chemical sector, employing 33,000 workers across five primary divisions including alkali products, explosives, metals, general chemicals, and dyestuffs by 1927. This scale enabled ICI to supply essential materials to virtually every major British industry, from via fertilizers to through dyes and alloys, fostering industrial interdependence and reducing reliance on foreign imports in the . At its mid-20th-century peak, ICI's global workforce reached approximately 130,000, with a substantial domestic component supporting through high-skilled jobs in , production, and operations; for instance, by the late 1970s, it maintained around 88,000 employees before shedding 22,000 (25% of its British staff) amid recessionary pressures in the early . The company's extensive network of facilities, including the Wilton chemical complex established in 1952 and wartime expansion to 25 plants producing explosives and strategic alloys, underscored its role in bolstering national self-sufficiency and industrial output during . ICI's export-oriented strategy further amplified its economic footprint, with European sales surging 33% annually from to and commanding over 50% of the ammonium market by 1975, contributing to Britain's through high-value chemical shipments. Innovations like , discovered in 1933, generated over 33,000 patents (and 150,000 worldwide), spurring downstream industries such as plastics and packaging, which multiplied economic value beyond direct sales—reaching £6.425 billion in group turnover by 2001. These advancements not only enhanced productivity in , textiles, and pharmaceuticals but also positioned ICI as a of post-war industrial modernization, though its cartel arrangements with international rivals like limited competitive dynamism in favor of coordinated scale. By the late , ICI's restructuring—such as the 1993 demerger creating Zeneca—refocused on high-margin specialties, sustaining contributions to UK value added in chemicals despite global pressures, though its bulk chemical reliance had declined from 40% of profits in 1979 to 16% by the 1990s. Overall, ICI's legacy lies in scaling chemical production to support broader , employing tens of thousands and driving export revenues that reinforced Britain's prowess amid 20th-century challenges.

International Operations

Global Expansion and Subsidiaries

ICI established its first major overseas subsidiaries in the late , focusing on dominions to leverage imperial trade networks and secure raw materials. In 1928, Imperial Chemical Industries of and Limited (ICIANZ) was incorporated as a to acquire and consolidate n chemical interests, including explosives from predecessor firms like Nobel (Australasia). Similarly, (CIL) operated as ICI's key Canadian arm, specializing in explosives, paints, and industrial chemicals, with full ownership by ICI confirmed in corporate reports from the era. These entities enabled localized production and distribution, reducing reliance on imports amid interwar economic pressures. Early international strategy emphasized agreements over direct investment, as seen in the 1929 nitrogen fixation pact with IG Farbenindustrie, which allocated sales quotas and territories in , , and South/ to avoid competition. This was extended in 1935, granting ICI exclusive nitrogen rights in select regions while ceding others, reflecting a pragmatic approach to global market division amid . By the 1930s, subsidiaries extended to and other colonies, supporting ICI's goal of chemical self-sufficiency for the . Post-World War II expansion targeted Europe and North America for technological and market growth. In 1965, ICI built fiber spinning facilities in West Germany and a polyvinyl chloride (PVC) plant in Bayonne, New Jersey, USA. The 1971 acquisition of Atlas Chemical Industries in the USA bolstered American operations in specialty chemicals. By the 1980s, ICI maintained subsidiaries in Argentina, China, France, India, Japan, Malaysia, Netherlands, Pakistan, and elsewhere, with further US investments including a 1977 paraquat plant in Bayport, Texas, and the 1986 purchase of Glidden Paints. These moves diversified revenue beyond cyclical bulk chemicals, though later debt from acquisitions like the 1997 Unilever specialties deal (£4.8 billion) strained finances.

Operations in Key Regions

ICI's operations in North America were spearheaded by the 1971 acquisition of Atlas Chemical Industries, which was reorganized as , encompassing activities in chemicals, explosives, and specialty products across the and . By 1987, the purchase of Stauffer Chemical expanded ICI's U.S. footprint, elevating annual sales from its American operations to over $4 billion and integrating facilities for , plastics, and industrial chemicals. Key sites included a large PVC plant in , and explosives production at Copperhead Chemical in , supporting defense and sectors until environmental efforts in later decades. In , ICI coordinated six subsidiaries focused on similar product lines, tying into broader operations that emphasized processing and downstream . In , ICI established a dedicated in 1928 as Imperial Chemical Industries (Australasia), later expanding to include and , which absorbed local firms such as Cuming, Smith & Co. and Fertilisers and Chemicals to consolidate production of , , , , and industrial chemicals. By the mid-20th century, these operations had grown into one of Australia's largest manufacturing entities, with major plants supporting and through and other , as well as pigments and polymers. ICI maintained a 62.4% stake until 1997, when the Australasian units were divested to form independent entities like for , reflecting a strategic shift toward regional amid global restructuring. Continental European operations, though secondary to and activities, included early investments in for general chemicals and joint ventures in dyes and synthetics, often constrained by post-World War I antitrust scrutiny and cartel dissolutions. Facilities in countries like the and supported paints, fibers, and pharmaceuticals, with ICI leveraging partnerships to access markets while navigating trade barriers; by the , these contributed to diversified exports but faced competition from local giants, leading to phased integrations post-acquisition by in 2008. Overall, ICI's regional strategies prioritized in resource-rich areas, with North American and Australasian sites emphasizing heavy chemicals tied to extractive industries.

Post-Acquisition International Legacy

Following the 2008 acquisition of Imperial Chemical Industries (ICI) by for £8 billion, ICI's international operations in paints and coatings were integrated into 's global structure, enhancing the latter's presence in over 150 countries. This merger created a combined entity with approximately 15% share of the global $85 billion coatings market, leveraging ICI's established brands and distribution networks in regions such as , , and . Key ICI brands like , originally developed by ICI, continued under as flagship products for decorative paints, distributed in more than 100 countries including the , , and parts of and . Similarly, the Coral brand, prominent in Latin American markets such as , was retained and expanded, contributing to AkzoNobel's growth in emerging economies through localized production and sales. Other ICI-derived lines, including Glidden and Cuprinol, supported international expansion by providing access to consumer and professional segments in and beyond. The legacy of ICI's pre-acquisition global subsidiaries, such as former operations in and focused on paints, persisted through AkzoNobel's retention and modernization of sites and supply chains. This integration facilitated synergies estimated at €300-400 million annually, primarily from overlapping international footprints, while non-core ICI assets like adhesives were divested to firms including to streamline global focus on high-value coatings. By 2011, AkzoNobel unified multiple ICI-inherited brands under initiatives like "Let's Colour," promoting standardized marketing across , , and , thereby sustaining ICI's influence on sustainable and decorative product innovations worldwide.

Governance and Strategy

Leadership and Key Executives

Imperial Chemical Industries (ICI) was established on December 4, 1926, via the amalgamation of four principal British chemical enterprises—Brunner, Mond & Co., Nobel Industries, United Alkali Company, and British Dyestuffs Corporation—with Sir Alfred Mond, head of Brunner Mond, appointed as the inaugural chairman and Sir Harry McGowan, from Nobel Industries, as managing director. This leadership duo drove the consolidation to counter international competition, particularly from German firms, achieving initial operations with 33,000 employees and £27 million turnover by 1927. Following Mond's death in 1930, McGowan succeeded as chairman and sole managing director, steering ICI through early expansion into synthetic products like Perspex in 1932 and in 1939. Subsequent chairmen included Sir , the first external appointee, who held the position from 1960 to 1968 and implemented structural reorganizations to enhance efficiency amid post-war diversification. Sir Peter Allen, an internal veteran who began as a works , followed as chairman from 1968 to 1971, overseeing acquisitions such as and the creation of Cleveland Potash Ltd. while navigating profit growth.
NameRoleTenure
Sir Alfred MondChairman1926–1930
Sir Harry McGowanManaging Director (later Chairman)1926–1930 (MD); 1930– (Chairman)
Sir Paul ChambersChairman1960–1968
Sir Peter AllenChairman1968–1971
Chairman1982–1987
, assuming chairmanship in 1982, marked a pivotal shift by divesting commoditized bulk chemicals in favor of pharmaceuticals and specialties, slashing costs, and elevating pre-tax profits beyond £1 billion by —the first for a firm—though later critiqued for vulnerability to takeovers. Later executives, including chief executive John McAdam from 2003, focused on cost reductions and emerging markets ahead of the 2008 acquisition, resulting in job cuts but temporary profit and share recovery. Charles Miller Smith, as chief executive around 2000, directed the 1997–2001 pivot to high-value paints and specialties.

Corporate Structure and Decision-Making

Imperial Chemical Industries (ICI) was incorporated on December 7, 1926, as a following the merger of four leading British chemical firms: Brunner Mond & Co., Nobel Industries Ltd., , and British Dyestuffs Corporation Ltd. The initial corporate structure reflected the product lines of these predecessors, organized into five autonomous divisions—Alkali Division, Explosives Division, General Chemicals Division, Dyestuffs Division, and Metals Division—each retaining significant operational independence while reporting to a central board headquartered at in from 1928. This divisional setup, employing around 33,000 workers by 1927, enabled coordinated production of commodities like soda ash, explosives, and synthetic dyes amid post-World War I competition. Governance centered on a chaired by Harry , managing director of Nobel Industries, who assumed the role in and maintained autocratic control over strategic decisions until his death in 1930, prioritizing cost efficiencies and market dominance through . Alfred Mond, from Brunner Mond, served as the first deputy chairman, contributing to early policy on fertilizers and , though 's influence dominated, fostering a top-down process that emphasized long-term capital investment over short-term profits. Board meetings and executive committees handled major capital allocations, such as the construction of works in 1924-1929 for synthetic , reflecting a consensus-driven yet hierarchical model suited to the era's cartel-like industry dynamics. Post-1930, under chairmen like Sir Amos (1930-1935) and later Lord McGowan's son, the structure evolved toward greater functional specialization, with centralized research at sites like Jealott's Hill (acquired 1928) informing divisional strategies, while production decisions decentralized to division heads for responsiveness to technological shifts like plastics development in . By the 1950s-1960s, amid threats and global expansion, ICI adopted a more matrix-like organization blending product divisions (e.g., emerging and Fibres) with regional subsidiaries, enabling decisions like the 1965 investments in ethylene crackers in Britain and PVC plants in the U.S. Decision-making intensified in the 1980s under CEO John Harvey-Jones (1982-1987), who restructured governance to prioritize performance metrics, divesting unprofitable bulk chemicals and redirecting resources to specialties like pharmaceuticals, yielding profits of £939 million by 1983 after prior losses. This era marked a shift to decentralized divisional accountability with board-level oversight on acquisitions, such as the 1997 purchase of Unilever's specialty chemical units for $8 billion, though persistent inefficiencies in legacy divisions contributed to the 1993 demerger of biosciences into Zeneca Group PLC, unlocking by separating high-growth segments from commoditized operations. By 2000, under CEO Charles Miller Smith, the board finalized a streamlined structure focused on paints and specialties, culminating in ICI's 2008 acquisition by , which integrated its divisions into a Dutch two-tier board system.

Strategic Shifts and Policy Influences

ICI's formation in 1926 through the merger of four leading British chemical firms—Nobel Industries, Brunner Mond, United , and British Dyestuffs —represented an initial strategic consolidation aimed at creating a national champion capable of competing with international giants like Germany's . This move was facilitated by government encouragement for industry rationalization in the , including support for technologies such as Brunner Mond's synthetic process in 1920 for explosives and fertilizers, reflecting policy priorities for self-sufficiency and export competitiveness amid post-World War I economic pressures. In the post-World War II era, ICI pursued diversification into pharmaceuticals (establishing ICI Pharmaceuticals in 1957), resins, and synthetic fibers, while facing scrutiny from the UK's Monopolies and Restrictive Practices Commission over its dominant market positions in heavy chemicals. Government policies promoting competition, such as the 1948 Monopolies and Restrictive Practices Act, prompted ICI to adjust pricing and distribution practices, though it retained significant influence without formal breakup. By the , proposed expansions like a merger with in man-made fibers were debated under monopoly referral powers, highlighting tensions between industrial consolidation and antitrust oversight. The 1980s marked a pivotal shift under chairman Sir John Harvey-Jones, with ICI pivoting from commodity chemicals like polyethylene to higher-margin specialties, including drugs, paints, and food chemicals, doubling pre-tax profits to £1 billion by 1984 amid global market liberalization. This realignment responded to stagnant commodity sales and intensified international competition, accelerated by Thatcher-era policies emphasizing deregulation, privatization, and shareholder value, which discouraged diversified conglomerates and favored focused entities. In 1993, ICI demerged its pharmaceuticals and agrochemicals into Zeneca, the UK's largest such split, to address portfolio complexity, mismatched management needs, and undervaluation risks from takeover bids like Hanson's approach, enabling each unit to pursue tailored growth strategies. Post-demerger, ICI emphasized specialties through 1997 acquisitions from for £4.8 billion, but mounting debt and divestiture challenges under continued competition pressures culminated in its 2008 acquisition by for £8 billion, underscoring policy-driven shifts toward efficiency over imperial-scale integration.

Controversies and Criticisms

Environmental and Health Impacts

Imperial Chemical Industries (ICI) operations, particularly at sites like and in the UK, generated significant environmental through chemical discharges, waste dumping, and emissions from , , and pigment production. Chlor-alkali processes at involved mercury-cell technology, resulting in effluent discharges containing 20-30 micrograms per liter of mercury, contributing to broader heavy metal contamination in local waterways and soils. Land remediation efforts at former ICI facilities have identified persistent contaminants including chlorinated organics, mercury, , and manufacturing wastes, necessitating extensive cleanups to address soil and . In February 2000, toxic fumes emanating from sealed quarries previously used by ICI for disposal in Weston Village near forced the evacuation of 16 families, highlighting ongoing risks from legacy dumps containing organochlorine compounds and other hazardous materials. The incident stemmed from anaerobic decomposition in the waste, releasing lethal gases into nearby residences, with residents reporting health concerns including respiratory irritation. At , early fertilizer production led to air and in the , prompting ICI's environmental improvement campaigns in the 1970s and subsequent restoration of affected sites like Saltholme Pools. A 1999 acid spill from ICI subsidiary Tioxide at polluted an adjacent , reviving public scrutiny of the company's controls. Health impacts on workers included exposure at ICI facilities, as evidenced by a 2025 court-approved settlement for a former employee who developed related illnesses due to breaches of the Factories Act 1961, underscoring inadequate historical protections in chemical plants. Public health effects near contaminated sites involved potential mercury and exposure to volatile organics, with studies in documenting elevated risks from industrial emissions over a century, though direct causation links remain debated due to multiple polluters. ICI's , formerly ICI Explosives, required EPA-led removals and groundwater investigations for and from explosive production residues. PFAS "forever chemicals" from legacy operations at sites like Hillhouse in have persisted in soils and , posing long-term risks to ecosystems and human health via water contamination, with ongoing investigations into pathways. In , ICI was fined £300,000 for a toxic leak causing , admitting failures in equipment maintenance that risked public exposure to hazardous effluents. These incidents reflect systemic challenges in early chemical manufacturing, where economic priorities often delayed adoption of stringent controls, though ICI later developed internal metrics like the Environmental Burden System to quantify and mitigate impacts.

Business and Monopoly Practices

Imperial Chemical Industries (ICI), formed on December 29, 1926, through the merger of Brunner, Mond & Co., Nobel Industries, United Alkali Company, and British Dyestuffs Corporation, rapidly achieved dominant market positions in the British chemical sector, controlling over 80% of domestic production in key areas such as alkalis, explosives, and dyestuffs by the early . This consolidation, intended to counter German competitors like , enabled ICI to engage in price leadership and exclusive supply agreements with downstream users, practices that limited entry by smaller firms and stabilized prices but drew scrutiny under emerging antitrust frameworks. In the UK, ICI's operations involved restrictive covenants, including non-compete clauses in supplier contracts and market-sharing understandings with remaining independents, which the Monopolies and Restrictive Practices (Inquiry and Control) Act of 1948 empowered the Monopolies Commission to investigate. Although formal probes into ICI's heavy chemicals sector in the found no overt predation, the company's and control over raw materials like salt and effectively deterred , contributing to higher domestic prices compared to international benchmarks. Internationally, ICI participated in cartels that divided global markets, notably through patent pooling and technology-sharing pacts. In the 1940s, U.S. antitrust actions revealed ICI's agreements with to allocate territories for and other synthetics, using cross-licensing to exclude rivals and maintain high prices; a 1952 enjoined such practices, requiring ICI to license patents freely in the U.S. Similarly, collateral agreements with firms like Solvay facilitated European market shares in soda ash and dyes, leading to European Commission fines in the 1969 dyestuffs case for concerted price increases averaging 15% across member states. These practices, while yielding short-term stability amid interwar volatility, fostered complacency and inefficiency, as evidenced by ICI's slower adoption of innovations compared to U.S. rivals; by the 1970s, antitrust pressures and market liberalization eroded its sheltered positions, prompting diversification efforts.

Labor Relations and Safety Incidents

ICI operated multiple chemical plants in the UK with inherent risks of fires, explosions, and toxic releases, leading to several documented safety incidents involving worker fatalities and injuries. In , at the Wilton works, approximately 5 tons of escaped from a storage vessel, forming a vapor cloud that migrated to a diesel-powered high-lift , where it ignited, killing two workers and causing a . The incident highlighted vulnerabilities in handling flammable liquids near ignition sources, prompting ICI to review transport and storage protocols for hazardous materials. Earlier, on April 25, 1940, an occurred in the coal-grinding of a boiler-house at ICI's facility, attributed to operational pressures during wartime production but with limited public details on casualties or causes beyond initial reports. ICI's internal safety publications, such as newsletters from the and , cataloged recurring issues like unauthorized connections leading to gas leaks and ignitions, as well as matches or open flames as ignition sources in one fatal case involving leaking gas mains. These records indicated a gradual reduction in the frequency and severity of such events through and procedural training, though chemical processing remained hazardous. In response to industry-wide lessons from the 1974 Flixborough explosion—which killed 28 at a Nypro supplying to ICI— the company's Petrochemicals Division audited its own large inventories and advocated for inherently safer design in project procedures, influencing process safety standards. Later operational incidents included a 1997 leak of at the ICI-owned Tioxide near , producing a cloud that necessitated closure and evacuations but reported no immediate fatalities. ICI's emphasis on internal reporting and mitigation reflected efforts to prioritize worker safety amid the causal risks of high-pressure chemical operations, though empirical data from these cases underscored persistent challenges in preventing and equipment failures. Labor relations at ICI involved standard with trade unions during the mid-20th century, aligned with the chemical sector's patterns of negotiation over wages and conditions, though major strikes specific to ICI appear limited in historical records compared to or industries. The company adopted employee representation models like works councils, as implemented in subsidiaries such as ICI and by the late , fostering consultation on issues including . This approach contributed to relative stability, with ICI's initiatives—such as newsletters dissecting incident causes—serving as tools for joint employer-union efforts to reduce hazards without widespread .

Legacy and Impact

Influence on British and Global Industry

Imperial Chemical Industries (ICI), formed in through the merger of four major British chemical firms, established dominance in the 's chemical sector, achieving near-monopoly positions in fertilizers, alkalis, soda ash, caustic soda, and synthetic dyes. This consolidation addressed vulnerabilities exposed during , fostering self-sufficiency in essential chemicals and supplying raw materials critical to upstream industries such as and production. By the mid-20th century, ICI employed tens of thousands in the , operating extensive facilities that underpinned national manufacturing output and exports, with its R&D investments—averaging 2-2.5% of sales—driving process and product advancements that integrated chemicals into broader industrial applications. ICI's innovations profoundly shaped British industry, including the development of in 1933, which revolutionized insulation for wartime and post-war packaging; Perspex ( polymer) in the early 1930s for canopies; and Terylene fiber patented in 1939, commercialized in 1950 to bolster textiles. These breakthroughs, alongside contributions to penicillin production and Fluothane anesthetic during , enhanced pharmaceutical capabilities and supported health-related sectors. In agriculture, herbicides like in the 1940s improved crop yields, influencing farming efficiency and . Globally, ICI extended influence through subsidiaries in markets serving 400 million people, exporting innovations that set standards in polymers and pharmaceuticals. emerged as the world's most common plastic post-World War II, enabling in and consumer goods worldwide, while pharmaceuticals such as the beta-blocker (Inderal, discovered 1958) and achieved broad therapeutic adoption. Crop protection agents like , despite later restrictions, maintained global use patterns. ICI's decentralized R&D model, emphasizing curiosity-driven research, contrasted with competitors like and influenced multinational chemical strategies, though its eventual breakup in the 1990s-2000s highlighted challenges from intensified global competition, leaving a persistent gap in chemical leadership.

Lessons from Decline and Restructuring

ICI's decline accelerated in the late amid stagnant demand for its legacy commodity chemicals and intensifying global competition, prompting a strategic reevaluation that exposed the conglomerate's internal value discrepancies. By 1991, an attempted takeover bid by Hanson Trust highlighted how ICI's pharmaceuticals and biosciences divisions were undervalued within the broader entity, as their growth potential outstripped the mature, low-margin chemicals operations. This prompted a major , culminating in the 1993 of its pharmaceuticals and biosciences into Zeneca Group PLC, which allowed the high-growth segment to operate independently and pursue specialized strategies unhindered by the chemicals division's capital demands. Post-demerger, the restructured ICI shifted toward specialty chemicals but incurred substantial debt through overvalued acquisitions, notably purchasing four divisions for £4.8 billion in 1997, which failed to deliver anticipated synergies or growth. This financial strain forced asset sales, including core British manufacturing assets, and deep cuts to , exacerbating underperformance as commodity chemical markets commoditized further. By 2007, ICI's had eroded significantly, leading to its £8 billion acquisition by Akzo Nobel, marking the end of its independent existence. Key lessons from ICI's trajectory underscore the perils of conglomerate structures, where cross-subsidization between disparate units—such as funding low-return chemicals from pharma profits—erodes overall and stifles focused . The successful evolution of Zeneca into via a 1999 merger illustrates the benefits of for unlocking hidden value in high-potential sectors, contrasting with ICI's post-split mismanagement through debt-fueled diversification into underperforming specialties. Overpayment in , without rigorous integration or market validation, amplified vulnerabilities to cyclical downturns, highlighting the need for disciplined capital allocation over empire-building. Finally, ICI's experience reflects broader challenges in mature industrial firms: sustained competitiveness demands relentless adaptation to technological shifts and global rivals, rather than reliance on historical scale, as evidenced by the erosion of R&D investment amid financial pressures.

Current Status and Successor Entities

Imperial Chemical Industries (ICI) ceased to operate as an independent entity following its acquisition by the Dutch company Akzo Nobel on January 2, 2008, in a transaction valued at £8 billion (approximately $15.8 billion). Akzo Nobel delisted ICI's shares from the London Stock Exchange and integrated its remaining operations, primarily in decorative paints and coatings including the brand, into its own structure, while divesting certain assets to comply with regulatory requirements. This marked the end of ICI as a standalone British chemical conglomerate, with its core businesses absorbed or redistributed. Prior to the acquisition, ICI had undergone significant demergers and disposals starting in the to focus on specialty chemicals and paints. In 1993, ICI demerged its pharmaceuticals, agrochemicals, and bioscience divisions into Zeneca Group PLC, distributing shares to ICI shareholders in a ratio reflecting the businesses' value. Zeneca merged with Sweden's in 1999 to form AstraZeneca PLC, which continues as a global pharmaceutical leader with annual revenues exceeding $45 billion as of 2023, retaining ICI's legacy in and other therapeutics. ICI's agrochemical heritage persisted through Zeneca's crop protection operations, which combined with Novartis's agri division in 2000 to create , a Swiss-based company specializing in seeds, pesticides, and . , now owned by Chinese state entities since 2017, operates over 100 manufacturing sites worldwide and generates more than $30 billion in annual revenue, continuing ICI-originated products like the under brands such as Gramoxone. Other key disposals included the 1999 sale of ICI's chemicals, selected , and (Tioxide) businesses to U.S.-based for $2.7 billion, bolstering Huntsman's position in performance products. Huntsman integrated these into its portfolio, later spinning off the titanium dioxide unit as Venator Materials in 2017 before reacquiring elements. Additionally, as part of the Akzo Nobel deal, ICI's National Starch adhesives business was transferred to Germany's AG & Co. KGaA to address antitrust concerns, enhancing Henkel's adhesives portfolio. These restructurings reflect ICI's shift from a diversified giant to fragmented successors focused on niche markets.

References

  1. https://www.fundinguniverse.com/company-histories/imperial-chemical-industries-plc-history/
  2. https://www.library.manchester.ac.uk/rylands/special-collections/a-to-z/detail/?mms_id=992983876595201631
  3. https://archives.sciencemuseumgroup.ac.uk/Details/archive/110048053
  4. https://www.referenceforbusiness.com/history2/20/Imperial-Chemical-Industries-Plc.html
  5. https://www.company-histories.com/Imperial-Chemical-Industries-PLC-Company-History.html
  6. https://alondoninheritance.com/tag/imperial-chemical-industries/
  7. https://law.justia.com/cases/federal/district-courts/FSupp/100/504/1502284/
  8. https://pubs.acs.org/doi/10.1021/cen-v029n041.p4173a
  9. https://hbr.org/1995/03/why-ici-chose-to-demerge
  10. https://www.theguardian.com/business/2007/aug/13/5
  11. https://www.icas.com/news-insights-events/documents/recording-an-empire-an-accounting-history-of-imperial-chemical-industries-ltd-1926-1976-2001
  12. https://archiveshub.jisc.ac.uk/data/gb133-ici
  13. https://www.sciencedirect.com/topics/pharmacology-toxicology-and-pharmaceutical-science/imperial-chemical-industries
  14. https://www.secretscotland.org.uk/index.php/Secrets/ICIArdeer
  15. https://www.devilsporridge.org.uk/tag/ici-powfoot
  16. https://www.encyclopedia.com/social-sciences-and-law/economics-business-and-labor/businesses-and-occupations/imperial-chemical-industries-plc
  17. https://teesvalleymuseums.org/blog/post/ici/
  18. https://www.gracesguide.co.uk/ICI_Billingham_Division
  19. https://placesjournal.org/article/the-mustard-gas-in-sherwood-forest/
  20. https://ahf.nuclearmuseum.org/manhattan-project-spotlight-rhydymwyn-valley-works/
  21. https://military-history.fandom.com/wiki/Tube_Alloys
  22. https://www.gracesguide.co.uk/ICI
  23. http://www.businesshistory.com/ind._chemicals.php
  24. https://www.upi.com/Archives/1993/02/25/ICI-to-go-ahead-with-split-cut-9000-jobs/9010730616400/
  25. https://www.thepharmaletter.com/zeneca-up-and-running-as-ici-splits
  26. https://uk.practicallaw.thomsonreuters.com/9-100-3791?transitionType=Default&contextData=%28sc.Default%29
  27. https://www.nytimes.com/1993/07/29/business/worldbusiness/IHT-a-tale-of-2-companiesici-zeneca-ready-results.html
  28. https://www.upi.com/Archives/1991/02/28/Imperial-Chemical-Industries-1990-profits-off-36-percent/4552667717200/
  29. https://www.wsj.com/articles/SB1013455116965999160
  30. http://news.bbc.co.uk/2/hi/business/319794.stm
  31. https://www.adhesivesmag.com/articles/83633-huntsman-ici-agree-to-terms-for-buyout-of-huntsman-international-stake
  32. https://www.theguardian.com/business/2007/jun/24/theobserver.observerbusiness5
  33. https://www.cnbc.com/2007/08/13/akzo-nobel-to-buy-ici-for-162-billion.html
  34. https://www.reuters.com/article/business/autos-transportation/akzo-nobel-agrees-to-buy-ici-for-162-bln-idUSL13670210/
  35. https://www.reuters.com/article/business/akzo-nobel-completes-ici-takeover-to-delist-shares-idUSL02137124/
  36. https://www.sec.gov/Archives/edgar/data/3124/000120864607000484/c97282.htm
  37. https://www.reuters.com/article/akzo-ici-divestments/eu-clears-purchase-of-britains-ici-by-akzo-nobel-idUSBFA00059220071214
  38. https://www.pcimag.com/articles/95269-akzo-nobel-completes-ici-acquisition-restructures-organization-posted-1-2-08
  39. https://www.akzonobel.com/content/dam/akzonobel-corporate/global/en/investor-relations-images/result-center/archive-annual-reports/2009-2000/Akzonobel-annual-report-2008.pdf
  40. https://europa.eu/rapid/pressReleasesAction.do?reference=IP/08/248
  41. https://www.akzonobel.com/en/about-us/our-history
  42. https://www.akzonobel.com/content/dam/akzonobel-corporate/global/en/investor-relations-images/result-center/archive-quarterly-results/2008-reports-and-presentations/q4/report-q4-and-full-year-2008-akzonobel.pdf
  43. https://www.theguardian.com/business/2009/feb/24/akzo-nobel-huge-loss
  44. https://www.marketingsociety.com/the-library/2008-dulux-global-branding-case-study
  45. https://www.chemistryworld.com/news/akzonobel-sells-ici-pakistan/5277.article
  46. https://www.business-live.co.uk/economic-development/end-era-dulux-sold-3964288
  47. https://www.gracesguide.co.uk/ICI_Paints_Division
  48. https://www.wikicorporates.org/wiki/Imperial_Chemical_Industries
  49. https://www.facebook.com/groups/2335508500011999/posts/4204406896455474/
  50. https://www.gracesguide.co.uk/ICI_Plastics
  51. https://www.huntsman.com/about/our-history
  52. https://naheritage.co.uk/stories/alfred-nobel
  53. https://www.gracesguide.co.uk/Nobel_Industries
  54. https://archiveshub.jisc.ac.uk/data/gb248-ugd089
  55. https://www.referenceforbusiness.com/history2/19/Imperial-Chemical-Industries-Plc.html
  56. https://www.ardrossanherald.com/news/23993707.ardeer-take-look-inside-former-ici-explosive-factory/
  57. https://pages.cs.wisc.edu/~anhai/wisc-si-archive/data/company_profiles/yahoo/instances/company-index/Basic_Materials/Chemical_Manufacturing/instances/http:%255E%255Ebiz.yahoo.com%255Ep%255Ei%255Eici.html
  58. https://pubs.acs.org/doi/10.1021/cen-v077n041.p017a
  59. https://www.icis.com/explore/resources/news/2008/05/12/9122447/polyethylene-discovered-by-accident-75-years-ago/
  60. https://www.edn.com/polyethylene-synthesis-is-discovered-by-accident-again-march-27-1933/
  61. https://lonestarchemical.com/plastic-its-not-all-the-same-the-history-of-polyethylene/
  62. https://www.perspex.co.uk/about-us/all-news/celebrating-90-years-of-perspex-acrylic/
  63. https://www.theguardian.com/business/2007/jun/18/2
  64. https://signupdate.co.uk/perspex-75-years/
  65. https://cameo.mfa.org/wiki/Terylene
  66. https://pubs.acs.org/doi/10.1021/cen-v033n006.p512
  67. https://www.thoughtco.com/history-of-polyester-4072579
  68. https://pmc.ncbi.nlm.nih.gov/articles/PMC1369014/
  69. https://www.nms.ac.uk/discover-catalogue/sir-james-black-the-pioneering-scottish-scientist-who-won-the-nobel-prize
  70. https://laskerfoundation.org/winners/propanolol-for-treating-heart-disease/
  71. https://www.soci.org/chemistry-and-industry/cni-data/2016/11/celebrating-ici
  72. https://www.gracesguide.co.uk/Winnington_Works
  73. https://www.gracesguide.co.uk/Jealott%27s_Hill_Research_Station
  74. https://www.tandfonline.com/doi/full/10.1080/00026980.2020.1794675
  75. https://collection.sciencemuseumgroup.org.uk/people/ap13079/imperial-chemical-industries-plc
  76. https://www.nytimes.com/1983/07/25/business/a-leaner-imperial-chemical.html
  77. https://www.orica.com/About-Us/History/History
  78. https://digital.library.mcgill.ca/images/hrcorpreports/pdfs/6/630609.pdf
  79. https://19january2017snapshot.epa.gov/hwcorrectiveactionsites/hazardous-waste-cleanup-copperhead-chemical-company-incorporated-formerly_.html
  80. https://www.upi.com/Archives/1987/06/05/Imperial-Chemical-Industries-PLC-in-move-to-accelerate-its/4628549864000/
  81. https://pubs.acs.org/doi/10.1021/cen-v052n026.p005
  82. https://www.austehc.unimelb.edu.au/tia/639.html
  83. https://www.orica.com/locations/australia-pacific-and-asia/australia/villawood-remediation/about-the-site/About-the-Site
  84. https://www.reuters.com/article/idUSL02137124/
  85. https://www.coatingsworld.com/akzonobel-to-expand-via-strong-sales-in-brazil/
  86. https://longtailasset.com/wp-content/uploads/2013/01/Jan-2017-Akzo-Nobel-enxtam_-AKZA.pdf
  87. https://www.pcimag.com/articles/87430-akzo-nobel-announces-details-of-proposed-ici-acquisition
  88. https://www.coatingsworld.com/breaking-news/akzonobel-consolidates-paint-brands-under-the-lets-colour-identity/
  89. https://pubs.acs.org/doi/10.1021/cen-v045n048.p022
  90. https://www.gracesguide.co.uk/ICI_Alkali_Division
  91. https://www.akzonobel.com/content/dam/akzonobel-corporate/global/en/regional-assets/uk---ireland/corporate-governance/s172-1-statement-imperial-chemical-industries-limited-2019.pdf
  92. https://catdir.loc.gov/catdir/samples/cam031/94009879.pdf
  93. https://hansard.parliament.uk/lords/1961-12-20/debates/92783476-52c3-4ced-aa10-bc2d085cb2d8/ProposedMergerOfIciAndCourtaulds
  94. https://www.reuters.com/article/business/ici-s-major-m-a-deals-idUSL18169218/
  95. https://www.endsreport.com/article/1577363/energy-effluent-costs-put-icis-chlorine-plants-line
  96. https://www.endsreport.com/article/1561303/ici-tackles-land-contamination
  97. https://www.theguardian.com/theguardian/2000/feb/11/features11.g2
  98. http://news.bbc.co.uk/2/hi/science/nature/635694.stm
  99. https://www.sciencemuseum.org.uk/objects-and-stories/our-environment/green-chemistry
  100. https://www.endsreport.com/article/1558519/major-tioxide-spill-revives-fears-icis-environmental-record
  101. https://www.leighday.co.uk/news/news/2025-news/substantial-settlement-for-chemical-factory-worker-exposed-to-asbestos-by-british-manufacturing-giant-ici/
  102. https://pmc.ncbi.nlm.nih.gov/articles/PMC2078512/
  103. https://www.groundsure.com/pfas-major-pollution-concerns/
  104. https://www.the-independent.com/news/pounds-300-000-slap-on-wrist-for-ici-after-toxic-leak-1149866.html
  105. https://www.researchgate.net/publication/229922939_Measuring_Corporate_Environmental_Performance_The_ICI_Environmental_Burden_System
  106. http://www.journals.uchicago.edu/doi/pdfplus/10.1086/257536
  107. https://law.justia.com/cases/federal/district-courts/FSupp/105/215/1975542/
  108. https://eur-lex.europa.eu/legal-content/EN/TXT/PDF/?uri=CELEX:62001TJ0066
  109. https://digitallibrary.un.org/record/831226/files/E_2675-EN.pdf
  110. https://journals.sagepub.com/doi/pdf/10.1177/0003603X7301800109
  111. https://archive.commercialmotor.com/article/5th-july-1974/64/icis-approach-to-the-arriage-of-hazardous-loads
  112. https://www.chemistryworld.com/opinion/letters-september-2024/4019998.article
  113. https://hansard.parliament.uk/commons/1940-04-25/debates/20c4e288-9cde-4c07-9a79-942caca82493/ExplosionBillingham
  114. https://www.icheme.org/media/10795/ici088.pdf
  115. https://www.icheme.org/media/10800/ici093.pdf
  116. https://www.icheme.org/media/10807/ici100.pdf
  117. https://ukopa.co.uk/wp-content/uploads/2025/07/Kletz-ICI-Paper.pdf
  118. https://www.the-independent.com/news/ici-closes-plant-after-gas-leak-1254341.html
  119. https://www.degruyterbrill.com/document/doi/10.1515/9783110850734-014/html
  120. https://classic.austlii.edu.au/au/journals/UNSWLawJl/2006/3.html
  121. https://content.time.com/time/subscriber/article/0%2C33009%2C889934%2C00.html
  122. https://www.chemistryworld.com/news/the-hole-in-the-uk-chemical-industry/4021309.article
  123. https://www.bbc.com/news/business-27391124
  124. https://www.bbc.co.uk/blogs/thereporters/robertpeston/2007/06/another_struggle_for_ici.html
  125. https://www.johnkay.com/the-high-cost-of-icis-fall-from-grace/?2024-09-11_105122_2490.html
Add your contribution
Related Hubs
User Avatar
No comments yet.